NYSE:GBS GBS (GBS) Stock Price, News & Analysis → Nvidia CEO Says It Will Be “the Next Revolution” Beyond AI (From Banyan Hill Publishing) (Ad) Free GBS Stock Alerts $2.80 +0.11 (+4.09%) (As of 04/29/2024 ET) Add Compare Share Share Today's Range$2.63▼$2.8250-Day Range$2.47▼$5.5252-Week Range$0.36▼$2.89Volume40,214 shsAverage Volume955,325 shsMarket Capitalization$41.69 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media Get GBS alerts: Email Address Ad Unstoppable ProsperityCharles Payne’s Gift to Stock InvestorsRight now, millions of good honest folks are feeling the squeeze. Last year's terrible market did a number on their accounts. Stock values plunged. Retirement accounts lost too.Watch Insider's Advantage Event Tuesday at 4:00 PM ET About GBS Stock (NYSE:GBS)GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.Read More GBS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GBS Stock News HeadlinesApril 27, 2024 | msn.comGB's Sawyers Devastated To Miss Olympics With InjuryApril 25, 2024 | sports.yahoo.comGB's Sawyers 'devastated' to miss Olympics with injuryApril 30, 2024 | Unstoppable Prosperity (Ad)Charles Payne’s Gift to Stock InvestorsRight now, millions of good honest folks are feeling the squeeze. Last year's terrible market did a number on their accounts. Stock values plunged. Retirement accounts lost too.April 25, 2024 | msn.comBrian Kilmeade Joins the Guy Benson Show and Talks the Trump TrialsApril 22, 2024 | americanbankingnews.comGlobus Medical (NYSE:GMED) and GBS (NYSE:GBS) Financial ComparisonApril 21, 2024 | msn.comHow to find and delete duplicate files on MacApril 20, 2024 | msn.comSri Lanka visa update: New online visa system introduced by Sri Lankan governmentApril 19, 2024 | msn.com'Strep B infection nearly killed me and my daughter'April 30, 2024 | Unstoppable Prosperity (Ad)Charles Payne’s Gift to Stock InvestorsRight now, millions of good honest folks are feeling the squeeze. Last year's terrible market did a number on their accounts. Stock values plunged. Retirement accounts lost too.April 18, 2024 | investing.comSolactive GBS Israel Large & Mid Cap TR (SILLMCT)April 16, 2024 | finanznachrichten.deHappiest Minds Technologies Limited: Happiest Minds develops GenAI chatbot for Happiest HealthApril 16, 2024 | finance.yahoo.comHappiest Minds develops GenAI chatbot for Happiest HealthApril 15, 2024 | investing.comSolactive GBS Israel Large & Mid Cap NTR (SILLMCN)April 15, 2024 | markets.businessinsider.comJoliet Junior College Partners With Canyon GBS(TM) for Advanced Enterprise AI With Advising App(TM)April 13, 2024 | msn.comTreating Chronic Inflammatory Demyelinating PolyneuropathyApril 13, 2024 | msn.comOntario man stranded in Costa Rica due to lack of hospital beds at homeApril 12, 2024 | finance.yahoo.comThe Barndo Co. Recognized at the Tenth Annual Bridge Awards GalaApril 12, 2024 | finance.yahoo.comHappiest Minds collaborates with ENERCON, to drive sustainable wind energy solutionsApril 11, 2024 | msn.comElucidating the link between Guillain–Barré syndrome and Takotsubo cardiomyopathyApril 10, 2024 | msn.com'Very disturbing': Leeds dog recovering after machete attack by teen ownerApril 9, 2024 | msn.comFamily pet attacked with machete in LeedsApril 9, 2024 | msn.com5 Linux commands you must know to keep your device running smoothlyApril 8, 2024 | msn.comGB's Page defends European women's trampoline titleApril 7, 2024 | msn.comGovernment Allocated Over ₹ 11 Lakh Crore To Indian Railways In Past Ten Years, RTI RevealsApril 4, 2024 | msn.comThe Best Dell Deals for April 2024April 3, 2024 | seekingalpha.comAnnexon: Unforced Error Sullies ProspectsApril 2, 2024 | finance.yahoo.comNew York Life Group Benefit Solutions Launches New Tool to Tackle Parental Leave UncertaintySee More Headlines Receive GBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GBS and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/31/2022Today4/29/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNYSE:GBS CUSIPN/A CIK1725430 Webwww.gbs.inc Phone646 828 8258FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.56) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,310,000.00 Net MarginsN/A Pretax Margin-1,907.09% Return on Equity-85.64% Return on Assets-54.42% Debt Debt-to-Equity RatioN/A Current Ratio2.33 Quick Ratio2.33 Sales & Book Value Annual Sales$440,000.00 Price / Sales94.75 Cash FlowN/A Price / Cash FlowN/A Book Value$0.44 per share Price / Book6.36Miscellaneous Outstanding Shares14,890,000Free Float14,850,000Market Cap$41.69 million OptionableNot Optionable Beta1.32 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesDr. Stephen Constantine Boyages M.D. (Age 64)MBBS, Ph.D., Interim CEO & Chairman Comp: $85.64kMr. Spiro Kevin Sakiris B.Bus (Age 60)C.A., CA, Dip Law, Chief Financial Officer Comp: $292.45kMr. Harry Simeonidis (Age 53)Pres of Asia Pacific Comp: $354.71kMs. Victoria Gavrilenko (Age 39)Operations Mang. Mr. Alex ArzenoVP of Investor RelationsKey CompetitorsCarmellNASDAQ:CTCXDarioHealthNASDAQ:DRIOBeyond AirNASDAQ:XAIRApyx MedicalNASDAQ:APYXInspireMDNYSE:NSPRView All Competitors GBS Stock Analysis - Frequently Asked Questions How have GBS shares performed in 2024? GBS's stock was trading at $0.3379 at the beginning of 2024. Since then, GBS shares have increased by 728.6% and is now trading at $2.80. View the best growth stocks for 2024 here. How were GBS's earnings last quarter? GBS Inc. (NYSE:GBS) announced its earnings results on Wednesday, August, 31st. The company reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.04. How do I buy shares of GBS? Shares of GBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:GBS) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 Media4 coins to be the “Next Bitcoin”True Market InsidersForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GBS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
